News | June 11, 2015

MRI Technology Reveals Deep Brain Pathways in Unprecedented Detail

Researchers hope to use technology to guide deep brain stimulation for Parkinson's patients, among others

Duke Medicine, MRI, deep brain stimulation, DBS, pathways, Nandan Lad

Image courtesy of Duke Medicine

June 11, 2015 - Scientists at Duke Medicine have produced a 3-D map of the human brain stem at an unprecedented level of detail using magnetic resonance imaging (MRI) technology.

In a study published June 3 in Human Brain Mapping, the researchers unveiled an ultra high-resolution brain stem model that could better guide brain surgeons treating conditions such as tremors and Parkinson's disease with deep brain stimulation (DBS).

The new 3-D model could eliminate risky trial-and-error as surgeons implant electrodes - a change akin to trading an outdated paper road atlas for a real-time GPS.

"On the conventional MRI that we take before surgery, the thalamus looks like a gray mass where you can see only the borders," said neurosurgeon Nandan Lad, M.D., Ph.D., director of the Duke NeuroOutcomes Center and an author of the paper. "Now we will have actual detail. With this map, for the first time we're able to see the thalamus and that underlying circuitry that we are modulating."

Many neurosurgeons currently rely on lower resolution computed tomography (CT) and MRI scans and geographic coordinates relative to the planes of the brain to guide them when placing electrodes into the thalamus. They are targeting a circuit called the dentatorubrothalamic tract or DRT (depicted as an X-shaped pathway in the accompanying image), Lad said.

Surgeons must often remove and reinsert electrodes and test frequencies to find the spots inside the thalamus where, for instance, the electric current subdues the hands of a patient with debilitating tremors. This indirect targeting is the standard of care for DBS, but comes with risk. Moving an electrode requires another pass through delicate tissue, and complications from DBS can include hemorrhage, seizure or memory problems.

"This map will potentially help us reach the optimal target the first time," Lad said. "It could eliminate trial and error and make the surgery safer."

The map was produced from a 10-day scan of a healthy donor's postmortem brain stem in a 7-Tesla MRI system, and then converted into a 3-D model that can be proportionally scaled to fit a person's unique brain anatomy using a high-performance computing cluster.

"These images are 1,000 times more detailed than a clinical MRI," said G. Allan Johnson, senior author of the paper and director of the Duke Center for In Vivo Microscopy where the brain stem was scanned. "You can actually see the nerve fibers in the brain, how they're crossing, and the subtleties of contrast between gray and white matter in the brain far beyond what a clinical scan could offer."

To test the accuracy of the model, the researchers conducted a retrospective study of 12 patients who had already been treated successfully for tremors using DBS. The researchers used the 3-D model to predict the best placement for the electrodes in each patient. The predictive computer model and the actual successful electrode placements correlated for 22 of 24 electrodes in the dozen patients, the study showed.

The researchers will soon begin a prospective study using the 3-D model to guide DBS surgery.

"As time goes on, imaging will only continue to get better," Lad said. "We are well-equipped and at the cutting edge of understanding how to apply this technology, and will be in an even better position to treat more patients with fewer side effects."

The Duke team will also pursue high resolution imaging of other circuits in the brain, brain stem and spinal cord to develop new treatments for other conditions.

"We now have a guide to be able to visualize these complex neuronal connections that would otherwise be impossible to see," said Evan Calabrese, Ph.D., the lead author of the paper who engineered the 3-D model. "This will help us continue to explore applications for treatments of Alzheimer's disease, neuropathic pain, depression and even obsessive compulsive disorders."

For more information: www.dukemedicine.org

Related Content

A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
February 15, 2018 — Arterys Inc. announced its fifth 510(k) clearance from the U.S.
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Videos | Pediatric Imaging | February 14, 2018
ITN Associate Editor Jeff Zagoudis demonstrates several mobile apps designed to help pediatric patients learn what an
Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
MedyMatch Receives FDA Device Designation for Intracranial Hemorrhage Software
News | Computed Tomography (CT) | February 01, 2018
February 1, 2018 – MedyMatch Technology, a company focused on helping physicians provide accurate patient assessment
Machine Learning Techniques Generate Clinical Labels of Medical Scans
News | Artificial Intelligence | January 31, 2018
Researchers used machine learning techniques, including natural language processing algorithms, to identify clinical...
Overlay Init